Drug interactions
Canagliflozin + Glimepiride-pioglitazone
Severity: Moderate
Canagliflozin and Glimepiride-pioglitazone: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Canagliflozin lowers glucose independently of insulin, and combined with the sulfonylurea glimepiride it increases the risk of hypoglycemia. Pioglitazone adds to the glucose-lowering burden.
What this interaction means in plain words
Canagliflozin and Glimepiride-pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Canagliflozin belongs to Endocrine; Glimepiride-pioglitazone belongs to Endocrine.
Why it happens
Additive glucose-lowering through insulin-independent urinary glucose excretion plus sulfonylurea-driven insulin secretion.
What to do
Consider lowering the glimepiride dose when starting canagliflozin and monitor blood glucose closely.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Canagliflozin and Glimepiride-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Glimepiride-pioglitazone
Other interactions of Canagliflozin
Frequently asked questions
Can I take Canagliflozin with Glimepiride-pioglitazone?
MediHelp rates the interaction as moderate. Canagliflozin and Glimepiride-pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Canagliflozin lowers glucose independently of insulin, and combined with the sulfonylurea glimepiride it increases the risk of hypoglycemia. Pioglitazone adds to the glucose-lowering burden.
How serious is the interaction between Canagliflozin and Glimepiride-pioglitazone?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider lowering the glimepiride dose when starting canagliflozin and monitor blood glucose closely.
What other medicines interact with Glimepiride-pioglitazone?
MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
